Journal article icon

Journal article

Gefitinib and EGFR gene copy number aberrations in esophageal cancer

Abstract:

Purpose: The Cancer Esophagus Gefitinib trial demonstrated improved progression-free survival with the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib relative to placebo in patients with advanced esophageal cancer who had disease progression after chemotherapy. Rapid and durable...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Publisher's version

Actions


Access Document


Files:
Publisher copy:
10.1200/JCO.2016.70.3934

Authors


Expand authors...
Expand funders...
Publisher:
American Society of Clinical Oncology Publisher's website
Journal:
Journal of Clinical Oncology Journal website
Volume:
35
Issue:
20
Pages:
2279-2287
Publication date:
2017-05-24
Acceptance date:
2017-03-28
DOI:
EISSN:
1527-7755
ISSN:
0732-183X
Pubs id:
pubs:697482
URN:
uri:5d4aeeb2-8629-4cd1-a8ba-6686ff2a3ad1
UUID:
uuid:5d4aeeb2-8629-4cd1-a8ba-6686ff2a3ad1
Local pid:
pubs:697482
Language:
English

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP